On Jun. 1, 2020, Tonix Pharmaceuticals announced an agreement whereby FUJIFILM Diosynth Biotechnologies will provide contract manufacturing and development services to support the manufacturing of Tonixﾒs COVID-19 vaccine candidate, TNX-1800, for clinical trial supply.

FUJIFILM will develop a manufacturing process, manufacture, and stock a supply of TNX-1800 at the company’s College Station, Texas site for Tonixﾒs clinical development.